Previous close | 0.6500 |
Open | 0.6500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 200.00 |
Expiry date | 2025-06-20 |
Day's range | 0.6500 - 0.6500 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Recently BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry upside down.
Major central banks have started lowering interest rates. With more cuts ahead, experts say it's important to position your investments accordingly.
Gilead Sciences and Nuvalent are in the spotlight following positive updates on key candidates.